Kieren Marr is the founder of Elion Therapeutics. Elion Therapeutics has raised $81M in total funding. Latest round: Series B.
Kieren Marr is the founder of Elion Therapeutics, a clinical-stage biotechnology company founded in 2024 focused on treating life-threatening invasive fungal infections. He also founded Pearl Diagnostics, Inc. Marr serves as the Founder of Elion Therapeutics and holds the email kmarr@eliontx.com.
Full founder directory · Investor directory · Company funding database · Fundraising library